← Back to Search
Chapter 14 – Late Effects After Radiation
M. Milano, L. Marks, L. Constine
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
This paper references
Dosimetric predictors of laryngeal edema.
G. Sanguineti (2007)
Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study.
E. Shaw (2002)
Dose-volume parameters of the corpora cavernosa do not correlate with erectile dysfunction after external beam radiotherapy for prostate cancer: results from a dose-escalation trial.
Gerard J van der Wielen (2008)
Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study.
J. Michalski (2010)
Relating radiation-induced regional lung injury to changes in pulmonary function tests.
M. Fan (2001)
Using generalized equivalent uniform dose atlases to combine and analyze prospective dosimetric and radiation pneumonitis data from 2 non-small cell lung cancer dose escalation protocols.
F. Liu (2013)
Penile bulb imaging.
K. Wallner (2002)
Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions.
C. Fiorino (2002)
Radiation dose-volume effects in the larynx and pharynx.
T. Rancati (2010)
Late cardiotoxicity after treatment for Hodgkin lymphoma.
B. Aleman (2007)
Small bowel dose parameters predicting grade ≥ 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques.
R. Banerjee (2013)
Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT).
S. Wang (2006)
Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases: results of the RTOG dose escalating protocol.
A. Russell (1993)
Is there a dose-response relationship for heart disease with low-dose radiation therapy?
Eugene Chung (2013)
Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
D. Schwartz (2010)
Quantifying local radiation-induced lung damage from computed tomography.
G. Ghobadi (2010)
Assessing correlations between the spatial distribution of the dose to the rectal wall and late rectal toxicity after prostate radiotherapy: an analysis of data from the MRC RT01 trial (ISRCTN 47772397).
F. Buettner (2009)
Regional differences in lung radiosensitivity after radiotherapy for non-small-cell lung cancer.
Y. Seppenwoolde (2004)
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial.
A. Pollack (2002)
Radiation dose-volume effects and the penile bulb.
M. Roach (2010)
A prospective comparison of neuropsychologic performance of children surviving leukemia who received 18-Gy, 24-Gy, or no cranial irradiation.
R. Mulhern (1991)
Persisting renotubular sequelae after cisplatin in children and adolescents.
M. Bianchetti (1991)
Dose to larynx predicts for swallowing complications after intensity-modulated radiotherapy.
H. Caglar (2008)
Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer.
E. H. Huang (2002)
Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: Dose-volume histogram analysis and comparison with conventional chemoradiation.
K. Tsujino (2006)
Rectal bleeding, fecal incontinence, and high stool frequency after conformal radiotherapy for prostate cancer: normal tissue complication probability modeling.
S. Peeters (2006)
Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study.
M. Roach (2004)
Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.
Xianglin Yuan (2009)
Cardiac toxicity and radiation dose to the heart in definitive treated non-small cell lung cancer
T. Schytte (2010)
Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histograms.
A. Jackson (2001)
Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.
Sonal Sura (2008)
Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time.
A. Lee (2002)
Radiation-associated liver injury.
Charlie C. Pan (2010)
Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
A. Eisbruch (2004)
Valvular dysfunction and carotid, subclavian, and coronary artery disease in survivors of hodgkin lymphoma treated with radiation therapy.
Matthew C. Hull (2003)
Proton-beam therapy for olfactory neuroblastoma.
H. Nishimura (2007)
Symptomatic coronary artery disease after mantle irradiation for Hodgkin's disease.
V. King (1996)
Neurocognitive function of patients with brain metastasis who received either whole brain radiotherapy plus stereotactic radiosurgery or radiosurgery alone.
H. Aoyama (2007)
Symptomatic cardiac toxicity is predicted by dosimetric and patient factors rather than changes in 18F-FDG PET determination of myocardial activity after chemoradiotherapy for esophageal cancer.
A. Konski (2012)
Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
J. Cheng (2002)
Radiation-induced injury to the visual pathway.
G. Jiang (1994)
Radiation pneumonitis and early circulatory cytokine markers.
Y. Chen (2002)
Renal complications secondary to radiation treatment of upper abdominal malignancies.
C. Willett (1986)
Dysphagia after definitive radiotherapy for head and neck cancer
L. Deantonio (2012)
Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors.
M. Martel (1997)
Clinical-dosimetric analysis of measures of dysphagia including gastrostomy-tube dependence among head and neck cancer patients treated definitively by intensity-modulated radiotherapy with concurrent chemotherapy
B. Li (2009)
Tolerance of the Small Bowel to Therapeutic Irradiation: A Focus on Late Toxicity in Patients Receiving Para-Aortic Nodal Irradiation for Gynecologic Malignancies
S. Stanić (2013)
Dose/volume relationship of late rectal bleeding after external beam radiotherapy for localized prostate cancer: absolute or relative rectal volume?
P. Kupelian (2002)
Change in diffusing capacity after radiation as an objective measure for grading radiation pneumonitis in patients treated for non-small-cell lung cancer.
J. L. Lopez Guerra (2012)
Sparing of the penile bulb and proximal penile structures with intensity-modulated radiation therapy for prostate cancer.
J. Kao (2004)
Whole-brain irradiation and decline in intelligence: the influence of dose and age on IQ score.
J. Silber (1992)
Different risks of symptomatic brain necrosis in NPC patients treated with different altered fractionated radiotherapy techniques.
Y. Jen (2001)
Cerebral radiation necrosis: incidence, outcomes, and risk factors with emphasis on radiation parameters and chemotherapy.
J. Ruben (2006)
Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy.
T. Kim (2007)
Radiation dose-volume effects in the spinal cord.
J. Kirkpatrick (2010)
Validation of normal tissue complication probability predictions in individual patient: late rectal toxicity.
V. Semenenko (2013)
Comparing different NTCP models that predict the incidence of radiation pneumonitis. Normal tissue complication probability.
Y. Seppenwoolde (2003)
Multivariate normal tissue complication probability modeling of heart valve dysfunction in Hodgkin lymphoma survivors.
L. Cella (2013)
Radiation dose-volume effects in radiation-induced rectal injury.
J. Michalski (2010)
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
M. Zelefsky (2008)
Improvement of local control of T3 and T4 nasopharyngeal carcinoma by hyperfractionated radiotherapy and concomitant chemotherapy.
J. Jian (2002)
Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique.
C. Amosson (2003)
Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
E. H. Pow (2006)
Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.
S. Peeters (2005)
Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease.
J. Cheng (2004)
Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
S. Yom (2007)
Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.
Young-Taek Oh (2004)
Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients.
M. Kam (2007)
Long-term parotid gland function after radiotherapy.
P. Braam (2005)
Predicting esophagitis after chemoradiation therapy for non-small cell lung cancer: an individual patient data meta-analysis.
D. Palma (2013)
Do dose-volume metrics predict pulmonary function changes in lung irradiation?
A. Allen (2003)
The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397).
G. Barnett (2011)
Radiation-induced pulmonary injury: symptomatic versus subclinical endpoints.
L. Marks (2000)
The radiation dose-response of the human spinal cord.
T. Schultheiss (2008)
Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
P. Levendag (2007)
Clinical and dosimetric factors of radiation-induced esophageal injury: radiation-induced esophageal toxicity.
Wen-Bo Qiao (2005)
Erectile dysfunction after prostate three-dimensional conformal radiation therapy
A. Magli (2012)
Intensity-modulated radiation therapy (IMRT) for meningioma.
N. Uy (2002)
Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study
M. Klein (2002)
Spinal cord tolerance to high-dose fractionated 3D conformal proton-photon irradiation as evaluated by equivalent uniform dose and dose volume histogram analysis.
L. Marucci (2004)
Unilateral radiation nephropathy--the long-term significance.
T. Kim (1984)
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy.
S. Ramella (2010)
Renal tolerance to nonhomogenous irradiation: comparison of observed effects to predictions of normal tissue complication probability from different biophysical models.
M. Flentje (1993)
Cognitive function in children with leukemia. Effect of radiation dose and time since irradiation
Ida Marie (Ki)Moore (1991)
A Little to a Lot or a Lot to a Little?
J. Willner (2003)
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response.
M. Skwarchuk (2000)
A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.
M. C. Vigliani (1996)
Long-term psychological effects in children treated for intracranial tumors.
L. Jannoun (1990)
The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation.
S. Aristizabal (1977)
Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications.
P. Teo (2000)
Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination.
P. Brown (2003)
Radiation-associated kidney injury.
L. Dawson (2010)
Quantitative measurement of changes in human lung density following irradiation.
K. Mah (1988)
Why avoid the hippocampus? A comprehensive review.
V. Gondi (2010)
Late swallowing dysfunction and dysphagia after radiotherapy for pharynx cancer: frequency, intensity and correlation with dose and volume parameters.
K. Jensen (2007)
Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy.
E. Wenkel (2000)
Erectile dysfunction and radiation dose to penile base structures: a lack of correlation.
U. Selek (2004)
Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.
C. Fiorino (2003)
Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
J. Caudell (2010)
Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis.
F. Kong (2006)
Prediction of radiation pneumonitis in lung cancer patients: a systematic review
X. Zhang (2012)
Cognitive performance after postoperative pituitary radiotherapy: a dosimetric study of the hippocampus and the prefrontal cortex.
P. Brummelman (2012)
Impact of salivary gland dosimetry on post-IMRT recovery of saliva output and xerostomia grade for head-and-neck cancer patients treated with or without contralateral submandibular gland sparing: a longitudinal study.
Z. Wang (2011)
Qantitative dose-volume response analysis of changes in parotid gland function after radiotheraphy in the head-and-neck region
J. Roesink (2001)
Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer.
H. Murshed (2004)
Predictive value of dose-volume histogram parameters for predicting radiation pneumonitis after concurrent chemoradiation for lung cancer.
K. Tsujino (2003)
Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer.
E. Jansen (2007)
Asymptomatic cardiac disease following mediastinal irradiation.
P. Heidenreich (2003)
Preservation of parotid function with uncomplicated conformal radiotherapy.
A. Maes (2002)
Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.
K. Rosenzweig (2000)
Salivary Gland Sparing and Improved Target Irradiation by Conformal and Intensity Modulated Irradiation of Head and Neck Cancer
A. Eisbruch (2003)
Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: the Centre de Protonthérapie D'Orsay experience.
G. Noël (2001)
Risk of long-term complications after TFG-beta1-guided very-high-dose thoracic radiotherapy.
M. Anscher (2003)
Biology contributionComparing different NTCP models that predict the incidence of radiation pneumonitis
Y. Seppenwoolde (2003)
Late complications of postoperative radiation therapy for cancer of the rectum and rectosigmoid.
A. C. Mak (1994)
A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results.
K. Chao (2001)
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas.
H. Gay (2012)
Neuropsychologic functioning of survivors of childhood medulloblastoma randomized to receive conventional or reduced-dose craniospinal irradiation: a Pediatric Oncology Group study.
R. Mulhern (1998)
Impact of patient-specific factors, irradiated left ventricular volume, and treatment set-up errors on the development of myocardial perfusion defects after radiation therapy for left-sided breast cancer.
E. S. Evans (2006)
A dosimetric analysis of acute gastrointestinal toxicity in women receiving intensity-modulated whole-pelvic radiation therapy.
J. Roeske (2003)
Heart irradiation as a risk factor for radiation pneumonitis
E. Huang (2011)
Radiation dose-volume effects in the brain.
Y. Lawrence (2010)
The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy.
Y. Li (2007)
Dose-volume tolerance of the brainstem after high-dose radiotherapy.
J. Debus (1999)
Radiation-induced middle ear and mastoid opacification in skull base tumors treated with radiotherapy.
G. Walker (2011)
Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC)
M. Graham (1999)
An improved model for predicting radiation pneumonitis incorporating clinical and dosimetric variables.
P. Jenkins (2011)
Association between radiation dose to neuronal progenitor cell niches and temporal lobes and performance on neuropsychological testing in children: a prospective study.
K. Redmond (2013)
Late cognitive and radiographic changes related to radiotherapy: Initial prospective findings
C. Armstrong (2002)
Radiation-induced pulmonary toxicity: a dose-volume histogram analysis in 201 patients with lung cancer.
M. L. Hernando (2001)
Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer
K. Henson (2013)
A prospective study on radiation-induced changes in hearing function.
F. Herrmann (2006)
Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.
K. Saarilahti (2006)
Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: an international individual patient data meta-analysis.
D. Palma (2013)
Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
G. Borst (2005)
Duodenal and other gastrointestinal toxicity in cervical and endometrial cancer treated with extended-field intensity modulated radiation therapy to paraaortic lymph nodes.
Philip D. Poorvu (2013)
Submandibular Gland-sparing Intensity-modulated Radiotherapy
W. Mendenhall (2014)
Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
Miranda E. Christianen (2012)
Treatment planning constraints to avoid xerostomia in head-and-neck radiotherapy: an independent test of QUANTEC criteria using a prospectively collected dataset.
V. Moiseenko (2012)
A comparative study of the long term psychosocial functioning of childhood acute lymphoblastic leukemia survivors treated by intrathecal methotrexate with or without cranial radiation
J. M. Hill (1998)
NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors.
I. Beetz (2012)
Normal tissue toxicity after small field hypofractionated stereotactic body radiation
M. Milano (2008)
An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma
M. Brown (2007)
Late effects of conformal radiation therapy for pediatric patients with low-grade glioma: prospective evaluation of cognitive, endocrine, and hearing deficits.
Thomas E. Merchant (2009)
Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients.
S. L. Kwa (1998)
Quantification of radiation-induced regional lung injury with perfusion imaging.
L. Marks (1997)
Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.
N. Laack (2005)
Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy.
M. Yin (2011)
Memory Preservation With Conformal Avoidance of the Hippocampus During Whole-Brain Radiation Therapy for Patients With Brain Metastases: Primary Endpoint Results of RTOG 0933
V. Gondi (2013)
Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix.
P. Eifel (1995)
Clinical dose-volume histogram analysis in predicting radiation pneumonitis in Hodgkin's lymphoma.
Eng-Siew Koh (2006)
Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.
A. Pederson (2012)
Coronary heart disease after radiotherapy for peptic ulcer disease.
Zhanat A Carr (2005)
Radiation dose delivered to the proximal penis as a predictor of the risk of erectile dysfunction after three-dimensional conformal radiotherapy for localized prostate cancer.
A. Wernicke (2004)
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
P. D. Maguire (1999)
Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
C. Vargas (2005)
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.
A. Singh (2003)
Long-term changes in pulmonary function tests after definitive radiotherapy for lung cancer.
K. L. Miller (2003)
Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: the role of dosimetric and clinical factors.
I. Beetz (2012)
Association between single nucleotide polymorphisms in the gene for XRCC1 and radiation-induced late toxicity in prostate cancer patients.
T. Langsenlehner (2011)
Tolerance of normal tissue to therapeutic irradiation.
B. Emami (1991)
Lack of Radiation Optic Neuropathy in 72 Patients Treated for Pituitary Adenoma
A. V. D. van den Bergh (2004)
A literature-based meta-analysis of clinical risk factors for development of radiation induced pneumonitis
I. Vogelius (2012)
Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma
S. Son (2013)
Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.
S. Tucker (2012)
Toxicity of thoracic radiotherapy on pulmonary function in lung cancer.
N. Choi (1994)
Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
P. Dirix (2009)
Dose-volume analysis of predictors for gastrointestinal toxicity after concurrent full-dose gemcitabine and radiotherapy for locally advanced pancreatic adenocarcinoma.
Jiayi Huang (2012)
Neurocognitive Impact of Whole Brain Radiation on Patients With Brain Metastases: Secondary Analysis of RTOG BR-0018
Y. Kwok (2007)
Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy
J. Grimm (2011)
Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.
M. M. Mac Manus (2011)
Influence of Age Upon Ifosfamide‐Induced Nephrotoxicity
J. McCune (2004)
Analysis of radiation-induced liver disease using the Lyman NTCP model.
L. Dawson (2002)
Dose-response relationships within the parotid gland after radiotherapy for head and neck cancer.
B. Bussels (2004)
Three-dimensional conformal radiotherapy for locally advanced (Stage II and worse) head-and-neck cancer: dosimetric and clinical evaluation.
M. Portaluri (2006)
Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
Y. Hitchcock (2009)
A phase II study of submandibular gland transfer prior to radiation for prevention of radiation-induced xerostomia in head-and-neck cancer (RTOG 0244).
N. Jha (2012)
Late GI and GU complications in the treatment of prostate cancer.
T. Schultheiss (1997)
Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy.
Z. Liao (2010)
Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience.
H. Mackley (2007)
Radiation optic neuropathy.
L. Kline (1985)
Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up
L. Douw (2009)
Radiation associated brainstem injury.
C. Mayo (2010)
Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses.
M. Daly (2007)
The incidence and functional consequences of RT-associated cardiac perfusion defects.
L. Marks (2005)
Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer.
T. Kim (2005)
Dosimetric and clinical predictors for radiation-induced esophageal injury.
S. Ahn (2005)
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
Reduction of radiation pneumonitis by V20-constraints in breast cancer
U. Goldman (2010)
Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients.
C. Pan (2005)
Brainstem tolerance to conformal radiotherapy of skull base tumors.
J. Debus (1997)
Radiation-associated cardiovascular disease.
M. Adams (2003)
Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer.
A. Eisbruch (2001)
Xerostomia after radiotherapy
S. Tribius (2012)
Visual complications following irradiation for pituitary adenomas and craniopharyngiomas.
J. Harris (1976)
Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters.
A. Gregor (1996)
Does altered fractionation influence the risk of radiation-induced optic neuropathy?
N. Bhandare (2005)
Intensity-modulated radiotherapy for resected mesothelioma: the Duke experience.
E. Miles (2008)
Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study.
M. Ris (2001)
Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates.
J. Schallenkamp (2007)
Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma
W. Chen (2006)
Comparison of rectal dose-wall histogram versus dose-volume histogram for modeling the incidence of late rectal bleeding after radiotherapy.
S. Tucker (2004)
Cardiac function after chemoradiation for esophageal cancer: comparison of heart dose-volume histogram parameters to multiple gated acquisition scan changes.
P. Tripp (2005)
Hippocampal dosimetry predicts neurocognitive function impairment after fractionated stereotactic radiotherapy for benign or low-grade adult brain tumors.
V. Gondi (2012)
Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertechnetate scintigraphy.
M. Muenter (2004)
Breast cancer: Risk of heart disease after radiotherapy—cause for concern
T. Zagar (2013)
Early variations of circulating interleukin-6 and interleukin-10 levels during thoracic radiotherapy are predictive for radiation pneumonitis.
D. Arpin (2005)
Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high‐risk acute lymphoblastic leukemia
D. Waber (2001)
Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.
J. Hayman (2001)
A longitudinal neuropsychological study of partial brain radiation in adults with brain tumors
I. Torres (2003)
Analysis of radiation-induced gastric and duodenal bleeds using the Lyman-Kutcher-Burman model
C. Pan (2003)
Use of normal tissue complication probability models in the clinic.
L. Marks (2010)
The use of 3-D dose volume analysis to predict radiation hepatitis.
T. Lawrence (1991)
Effect of normal lung definition on lung dosimetry and lung toxicity prediction in radiation therapy treatment planning.
Weili Wang (2013)
Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 GY) conformal radiotherapy for prostate cancer, using dose-volume histograms.
L. Boersma (1998)
Radiation therapy and hearing loss.
N. Bhandare (2010)
Protection of salivary function by intensity-modulated radiation therapy in patients with head and neck cancer.
K. Chao (2002)
"Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics.
D. Kahn (2005)
Coronary artery disease and breast radiation therapy.
R. Pezner (2013)
A comparison of mean parotid gland dose with measures of parotid gland function after radiotherapy for head-and-neck cancer: implications for future trials.
J. Roesink (2005)
Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
A. Blanco (2005)
Dose-volume histogram analysis as predictor of radiation pneumonitis in primary lung cancer patients treated with radiotherapy.
M. Fay (2005)
Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia.
E. Smibert (1996)
Radiation dose-volume effects in the esophagus.
M. Werner-wasik (2010)
A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data.
J. Bradley (2007)
Radiotherapy dose-volume effects on salivary gland function.
J. Deasy (2010)
Conformal arc radiotherapy for prostate cancer: increased biochemical failure in patients with distended rectum on the planning computed tomogram despite image guidance by implanted markers.
B. Engels (2009)
Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney.
L. Dewit (1993)
Fraction size and dose parameters related to the incidence of pericardial effusions.
M. Martel (1998)
Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.
J. T. Parsons (1994)
A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints.
A. Ahmed (2013)
Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
S. Hancock (1993)
Late Xerostomia After Intensity-Modulated Radiation Therapy Versus Conventional Radiotherapy
H. Pacholke (2005)
Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: the Paul Scherrer Institut experience.
D. Weber (2005)
Partial irradiation of the heart.
G. Gagliardi (2001)
Predicting pneumonitis risk: a dosimetric alternative to mean lung dose.
S. Tucker (2013)
Late radiation injuries of the gastrointestinal tract in the H2 and H5 EORTC Hodgkin's disease trials: emphasis on the role of exploratory laparotomy and fractionation.
J. M. Cosset (1988)
Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
Xiong Wei (2008)
Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
S. H. Chan (2009)
Evaluating the relationship between erectile dysfunction and dose received by the penile bulb: using data from a randomised controlled trial of conformal radiotherapy in prostate cancer (MRC RT01, ISRCTN47772397).
S. Mangar (2006)
Localized volume effects for late rectal and anal toxicity after radiotherapy for prostate cancer.
S. Peeters (2006)
Radiation dose-volume effects in the lung.
L. Marks (2010)
Long-term cardiac mortality after radiotherapy of breast cancer--application of the relative seriality model.
G. Gagliardi (1996)
Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.
K. de Jaeger (2003)
White matter changes are correlated significantly with radiation dose. Observations from a randomized dose‐escalation trial for malignant glioma (radiation therapy oncology group 83‐02)
B. Corn (1994)
Preliminary analysis of risk factors for late rectal toxicity after helical tomotherapy for prostate cancer
N. Tomita (2013)
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial
C. Nutting (2011)
Predictive factors for radiation pneumonitis in Hodgkin lymphoma patients receiving combined-modality therapy.
A. M. Fox (2012)
Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
C. Cozzarini (2003)
Ototoxicity after radiotherapy for head and neck tumors.
N. Bhandare (2007)
Lhermitte's Sign Developing after IMRT for Head and Neck Cancer
D. C. Lim (2010)
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer.
Gordon O. Schoenfeld (2008)
The dose-volume realationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer
K. Baglan (2002)
Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.
E. Yorke (2002)
A randomized phase III study of accelerated hyperfractionation versus standard in patients with unresected brain metastases: a report of the Radiation Therapy Oncology Group (RTOG) 9104.
K. Murray (1997)
Can we predict radiation-induced changes in pulmonary function based on the sum of predicted regional dysfunction?
M. Fan (2001)
Permanent unilateral hearing loss after radiotherapy for parotid gland tumors
L. van der Putten (2006)
The Potential Nephrotoxic Effects of Intensity Modulated Radiotherapy Delivered to the Para-Aortic Area of Women With Gynecologic Malignancies: Preliminary Results
J. Varlotto (2006)
Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
J. Bradley (2005)
ATM polymorphisms are associated with risk of radiation-induced pneumonitis.
L. Zhang (2010)
Long-term changes in pulmonary function after incidental lung irradiation for breast cancer: a prospective study with 7-year follow-up.
J. Jaén (2012)
Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures.
F. Feng (2007)
Duodenal toxicity after fractionated chemoradiation for unresectable pancreatic cancer.
P. Kelly (2013)
Effect of time, dose, and fractionation on temporal lobe necrosis following radiotherapy for nasopharyngeal carcinoma.
A. Lee (1998)
Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
L. Marks (1997)
Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.
H. Honoré (2002)
Radiation dose-volume effects of the urinary bladder.
A. Viswanathan (2010)
Radiation dose-volume effects of optic nerves and chiasm.
C. Mayo (2010)
Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer.
A. Eisbruch (1999)
A predictive model for dysphagia following IMRT for head and neck cancer: introduction of the EMLasso technique.
K. De Ruyck (2013)
Radiation dose-volume effects in the stomach and small bowel.
B. Kavanagh (2010)
Long-term cardiac mortality following radiation therapy for Hodgkin's disease: analysis with the relative seriality model.
F. Eriksson (2000)
Risk of ischemic heart disease in women after radiotherapy for breast cancer.
S. Darby (2013)
Distribution of coronary artery stenosis after radiation for breast cancer.
G. Nilsson (2012)
Renal toxicity of adjuvant chemoradiotherapy with cisplatin in gastric cancer.
S. Welz (2007)
Radiation fibrosis of the vocal fold: From man to mouse
M. Johns (2012)
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)
Promising survival with three-dimensional conformal radiation therapy for non-small cell lung cancer.
J. Armstrong (1997)
Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer
V.E.M. Mul (2011)
Neurocognitive outcomes decades after treatment for childhood acute lymphoblastic leukemia: a report from the St Jude lifetime cohort study.
K. Krull (2013)
Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?
A. P. Jellema (2005)
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancer.
S. Narayan (2004)
Early neuro-otologic effects of three-dimensional irradiation in children with primary brain tumors.
T. Merchant (2004)
Reducing xerostomia after chemo-IMRT for head-and-neck cancer: beyond sparing the parotid glands.
M. Little (2012)
The effect of irradiation on lung function and perfusion in patients with lung cancer.
R. Abratt (1995)
Phase I/II trial of accelerated fractionation in brain metastases RTOG 85-28.
W. Sause (1993)
Prediction of radiation pneumonitis: dose-volume histogram analysis in 62 patients with non-small cell lung cancer after three-dimensional conformal radiotherapy.
T. Piotrowski (2005)
Effect of dose and dose-distribution in damage to the kidney following abdominal radiotherapy
S. Köst (2002)
Small molecular inhibitor of transforming growth factor-beta protects against development of radiation-induced lung injury.
M. Anscher (2008)
Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors.
S. Wachter (2001)
Change in Creatinine Clearance Over Time Following Upper Abdominal Irradiation: A Dose-Volume Histogram Multivariate Analysis
V. Diavolitsis (2011)
Predicting radiotherapy-induced cardiac perfusion defects.
S. Das (2005)
Neuropsychological outcomes from a randomized trial of triple intrathecal chemotherapy compared with 18 Gy cranial radiation as CNS treatment in acute lymphoblastic leukemia: findings from Dana-Farber Cancer Institute ALL Consortium Protocol 95-01.
D. Waber (2007)
Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer.
B. M. Fisch (2001)
Radiation doses to structures within and adjacent to the larynx are correlated with long-term diet- and speech-related quality of life.
Ken Dornfeld (2007)
ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer.
P. Lind (2006)
Challenges in defining radiation pneumonitis in patients with lung cancer.
Z. Koçak (2005)
Postoperative intensity‐modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: Technique, early outcomes, and toxicity
B. Hoppe (2008)
Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy.
M. Yang (2011)
Factors associated with neurological recovery of brainstem function following postoperative conformal radiation therapy for infratentorial ependymoma.
T. Merchant (2010)
Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters.
A. Hope (2006)
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
E. Yorke (2005)
Predictive factors of late radiation fibrosis: a prospective study in non-small cell lung cancer.
R. Mazeron (2010)
Orbital lymphoma: is it necessary to treat the entire orbit?
M. Pfeffer (2004)
Use of Veff and iso-NTCP in the implementation of dose escalation protocols.
R. Ten Haken (1993)
This paper is referenced by
The Effect of Cognitive–Oriented Video Games on Executive Functions of Preschool Children with Neuropsychological Learning Disabilities
Afsaneh Jafarabadi (2016)